rLOAD: Does sex mediate the effect of acute antiplatelet loading on stroke outcome

Biology of Sex Differences

Volumn 5, Issue 1, 2014, Pages

  Meyer, Dawn M ^a   Eastwood, Jo Ann ^b   Compton, Peggy M ^c   Gylys, Karen ^b   Zivin, Justin A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute stroke; Antiplatelet; Aspirin; Stroke model

Indexed keywords

EID: 84905408274     PISSN: None     EISSN: 20426410     Source Type: Journal    
DOI: 10.1186/2042-6410-5-9     Document Type: Article

References (49)

1. Lisabeth LD, Brown DL, Morgenstern LB: Barriers to intravenous tissue plasminogen activator for acute stroke therapy in women. Gend Med 2006, 3:270-275.
2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, et al: Heart disease and stroke statistics - 2014 update: a report from the American heart association. Circulation 2013, 127(23):e841.
3. Reeves MJ, WIlkins T, Lysbeth L, Schwamm L: Thrombolysis treatment for acute stroke: issues of efficacy and utilization in women. Womens Health (Lond Engl) 2011, 7:383-390.
4. de Ridder I, Dirks M, Niessen L, Dippel D: Unequal access to treatment with intravenous alteplase for women with acute ischemic stroke. Stroke 2013, 44:2610-2612.
5. Mitka M: New guidelines focus on preventing stroke in women. JAMA 2014, 311:1003-1004.
6. Roy-O'Reilly M, McCullough LD: Sex differences in stroke: the contribution of coagulation. Exp Neurol 2014. doi:10.1016/j.expneurol.2014.02.011.
7. Hurn PD, Macrae IM: Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 2000, 20:631-652.
8. Green PS, Simpkins JW: Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci 2000, 18:347-357.
9. Meyer DM, Compton P, Eastwood J-A, Gylys K, Zivin JA: Antiplatelet loading improves behavioral outcome in a rabbit model of stroke. Stroke 2013, 44(11):3246-8.
10. Zivin JA, DeGirolami U: A new approach in the experimental investigation of stroke. Trans Am Neurol Assoc 1980, 105:161-172.
11. Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak KA: Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 1985, 230:1289-1297.
12. Lapchak PA, Araujo DM, Song D, Wei J, Zivin JA: Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1, 3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke 2002, 33:1411-1415.
13. Chapman DF, Lyden P, Lapchak PA, Nunez S, Thibodeaux H, Zivin J: Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model. Stroke 2001, 32:748.
14. Lapchak PA, Araujo DM, Pakola S, Song D, Wei J, Zivin JA: Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits. Stroke 2002, 33:2279.
15. Lapchak PA, Araujo DM, Song D, Wei J, Purdy R, Zivin J: Pharmacological effects of the spin trap agent disodium-[(tert-butylimino)methyl] benzene-1,3-disulfonate N-oxide (Generic NXY-059) on intracerebral hemorrhage in a rabbit large clot thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator (tPA). Stroke 2002, 33:1665.
16. Lapchak PA, Wei J, Zivin JA: Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits. Stroke 2004, 35:1985-1988.
17. Lapchak P: Development of thrombolytic therapy for stroke: a perspective. Expert Opin Investig Drugs 2002, 11:1623-1626.
18. Schlitt A, Hauroeder B, Buerke M, Peetz D, Victor A, Hundt F, Bickel C, Meyer J, Rupprecht HJ: Effects of combined therapy of clopidogrel and aspirin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model. Thromb Res 2002, 107:39-47.
19. Wong PC, Crain EJ, Watson CA, Jiang X, Hua J, Bostwick JS, Ogletree ML, Schumacher WA, Rehfuss R: Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits. J Cardiovasc Pharmacol 2007, 49:316-324.
20. Born GV: Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962, 194:927-929.
21. Rinaldi S, Dechaud H, Biessy C, Morin-Raverot V, Toniolo P, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, Secreto G, Ciampi A, Riboli E, Kaaks R: Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2001, 10:757-765.
22. Meyer DM, Albright KC, Allison TA, Grotta JC: LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2008, 17:26-29.
23. Jauch EC, Saver JL, Adams HP Jr, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW Jr, Qureshi AI, Rosenfield K, Scott PA, Summers DR, Wang DZ, Wintermark M, Yonas H, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Clinical Cardiology: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Circulation 2007, 115:e478-e534.
24. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Sacco RL, Schwamm LH, American Heart Association; American Stroke Association: Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008, 39:1647-1652.
25. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994, 308:81-98.
26. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM: Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007, 6:961-968.
27. Mendelsohn ME: Protective effects of estrogen on the cardiovascular system. Am J Cardiol 2002, 89:12-22.
28. Orshal JM, Khalil RA: Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004, 286:R233-R249.
29. Dietrich JB: Endothelial cells of the blood-brain barrier: a target for glucocorticoids and estrogens? Front Biosci 2004, 9:684-693.
30. Alevriadou BR: CAMs and Rho small GTPases: gatekeepers for leukocyte transendothelial migration. Focus on "VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration". Am J Physiol Cell Physiol 2003, 285:C250-C257.
31. Lang J, McCullough L: Pathways to ischemic neuronal cell death: are sex differences relevant. J Transl Med 2008, 6:1-12.
32. Behl C: Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 2002, 3:433-441.
33. Horsburgh K, Macrae IM, Carswell H: Estrogen is neuroprotective via an apolipoprotein E-dependent mechanism in a mouse model of global ischemia. J Cereb Blood Flow Metab 2002, 22:1189-1195.
34. Duckles SP, Krause DN, Stirone C, Procaccio V: Estrogen and mitochondria: a new paradigm for vascular protection? Mol Interv 2006, 6:26-35.
35. Miller VM, Mulvagh SL: Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci 2007, 28:263-270.
36. McCulloch J, Dewar D: A radical approach to stroke therapy. Proc Natl Acad Sci U S A 2001, 98:10989-10997.
37. Suzuki S, Brown CM, Wise PM: Mechanisms of neuroprotection by estrogen. Endocrine 2006, 29:209-215.
38. Carswell HVO, Dominiczak AF, Macrae IM: Estrogen status affects sensitivity to focal cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2000, 278:H290-H294.
39. Toung TK, Hurn PD, Traystman RJ, Sieber FE, Faraci FM: Estrogen decreases infarct size after temporary focal ischemia in a genetic model of type 1 diabetes mellitus editorial comment. Stroke 2000, 31:2701-2706.
40. Liao S-L, Chen W-Y, Kuo J-S, Chen C-J: Association of serum estrogen level and ischemic neuroprotection in female rats. Neurosci Lett 2001, 297:159-166.
41. Pappa T, Vemmos K, Mantzou E, Savvari P, Stamatelopoulos K, Alevizaki M: Estradiol levels predict short-term adverse health outcomes in postmenopausal acute stroke women. Eur J Neurol 2012, 19:1300-1304.
42. Manwani B, McCullough LD: Estrogen in ischaemic stroke: the debate continues. Eur J Neurol 2012, 19:1276-1277.
43. Krause DN, Duckles SP, Pelligrino DA: Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 2006, 101:1252-1261.
44. Egido JA, Alonso de Lecinana M: Peculiarities of stroke risk in women. Cerebrovasc Dis 2007, 24(Suppl 1):76-83.
45. Fukuda K, Yao H, Ibayashi S, Nakahara T, Uchimura H, Fujishima M, Hall ED: Ovariectomy exacerbates and estrogen replacement attenuates photothrombotic focal ischemic brain injury in rats editorial comment. Stroke 2000, 31:155-160.
46. Santizo RA, Xu H-L, Ye S, Baughman VL, Pelligrino DA: Loss of benefit from estrogen replacement therapy in diabetic ovariectomized female rats subjected to transient forebrain ischemia. Brain Res 2002, 956:86-91.
47. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL: Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 1997, 87:724-729.
48. Wang Q, Santizo R, Baughman VL, Pelligrino DA, Iadecola C: Estrogen provides neuroprotection in transient forebrain ischemia through perfusion-independent mechanisms in rats • editorial comment. Stroke 1999, 30:630-637.
49. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD, Miller VM: Neuroprotective effects of female gonadal steroids in reproductively senescent female rats editorial comment. Stroke 2000, 31: 161-168.